These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10943587)

  • 1. Antisense and gene therapy to prevent restenosis.
    Ehsan A; Mann MJ
    Vasc Med; 2000; 5(2):103-14. PubMed ID: 10943587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
    von der Leyen HE; Mann MJ; Dzau VJ
    Semin Interv Cardiol; 1996 Sep; 1(3):209-14. PubMed ID: 9552513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on gene therapy for intimal hyperplasia.
    Reis ED; Skladany M
    Bratisl Lek Listy; 1999 Aug; 100(8):417-21. PubMed ID: 10645028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
    Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
    Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of intimal hyperplasia by gene therapy: an update].
    Reis E; Martinet O; Mosimann F
    J Mal Vasc; 1999 Dec; 24(5):349-55. PubMed ID: 10642646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for vascular disease.
    Svensson EC; Schwartz LB
    Curr Opin Cardiol; 1998 Sep; 13(5):369-74. PubMed ID: 9823792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy techniques for peripheral arterial disease.
    Manninen HI; Mäkinen K
    Cardiovasc Intervent Radiol; 2002; 25(2):98-108. PubMed ID: 11901426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular gene therapy: current status and therapeutic potential.
    Gaffney MM; Hynes SO; Barry F; O'Brien T
    Br J Pharmacol; 2007 Sep; 152(2):175-88. PubMed ID: 17558439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.
    Mitra AK; Agrawal DK
    Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease.
    Morishita R; Aoki M; Kaneda Y
    Ann N Y Acad Sci; 2001 Dec; 947():294-301; discussion 301-2. PubMed ID: 11795277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides as therapeutic agents.
    Galderisi U; Cascino A; Giordano A
    J Cell Physiol; 1999 Nov; 181(2):251-7. PubMed ID: 10497304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
    J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular gene therapy.
    Ylä-Herttuala S; Martin JF
    Lancet; 2000 Jan; 355(9199):213-22. PubMed ID: 10675133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation.
    Muhs A; Heublein B; Schletter J; Herrmann A; Rüdiger M; Sturm M; Grust A; Malms J; Schrader J; von der Leyen HE
    Hum Gene Ther; 2003 Mar; 14(4):375-83. PubMed ID: 12659678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense strategies to inhibit restenosis.
    Lee M; Simon AD; Stein CA; Rabbani LE
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):487-92. PubMed ID: 10555157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for the extension of vein graft patency: a review.
    Chandiwal A; Balasubramanian V; Baldwin ZK; Conte MS; Schwartz LB
    Vasc Endovascular Surg; 2005; 39(1):1-14. PubMed ID: 15696243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene therapy of cardiovascular disorders].
    Kaneda Y; Morishita R
    Hum Cell; 1999 Sep; 12(3):109-14. PubMed ID: 10695017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.